drugset / Trial / NCT00131287

The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)

NCT00131287 ↗

Phase 3 Completed 108 enrolled ECbiotech Taiwan
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.

Timeline

Start
2005-07
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Extract of Agaricus blazei Murill Unknown — —